- Home
- TIGO vs RVMD Comparison
TIGO vs RVMD Comparison
Compare TIGO & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIGO
- RVMD
- Stock Information
- Founded
- TIGO 1990
- RVMD 2014
- Country
- TIGO Luxembourg
- RVMD United States
- Employees
- TIGO N/A
- RVMD N/A
- Industry
- TIGO Telecommunications Equipment
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TIGO Telecommunications
- RVMD Health Care
- Exchange
- TIGO Nasdaq
- RVMD Nasdaq
- Market Cap
- TIGO 7.8B
- RVMD 7.5B
- IPO Year
- TIGO 1994
- RVMD 2020
- Fundamental
- Price
- TIGO $50.49
- RVMD $67.76
- Analyst Decision
- TIGO Hold
- RVMD Strong Buy
- Analyst Count
- TIGO 5
- RVMD 17
- Target Price
- TIGO $43.76
- RVMD $77.24
- AVG Volume (30 Days)
- TIGO 748.8K
- RVMD 2.4M
- Earning Date
- TIGO 11-06-2025
- RVMD 11-05-2025
- Dividend Yield
- TIGO 5.96%
- RVMD N/A
- EPS Growth
- TIGO 601.37
- RVMD N/A
- EPS
- TIGO 6.46
- RVMD N/A
- Revenue
- TIGO $5,594,000,000.00
- RVMD N/A
- Revenue This Year
- TIGO N/A
- RVMD N/A
- Revenue Next Year
- TIGO $7.81
- RVMD $537.73
- P/E Ratio
- TIGO $7.78
- RVMD N/A
- Revenue Growth
- TIGO N/A
- RVMD N/A
- 52 Week Low
- TIGO $23.61
- RVMD $29.17
- 52 Week High
- TIGO $51.80
- RVMD $69.02
- Technical
- Relative Strength Index (RSI)
- TIGO 62.16
- RVMD 81.26
- Support Level
- TIGO $46.85
- RVMD $58.91
- Resistance Level
- TIGO $51.80
- RVMD $63.15
- Average True Range (ATR)
- TIGO 1.60
- RVMD 2.39
- MACD
- TIGO 0.41
- RVMD 0.43
- Stochastic Oscillator
- TIGO 81.94
- RVMD 90.13
About TIGO Millicom International Cellular S.A.
Millicom offers wireless and fixed-line telecom services primarily in smaller, less developed countries in Latin America. Countries served include Bolivia (100% owned), Nicaragua (100%), Panama (100%), El Salvador (100%), Guatemala (100%), Paraguay (100%), Colombia (50%), and Honduras (67% but not controlled or consolidated in the firm's financial statements). The firm's wireless networks cover about 120 million people, serving 42 million customers. Its fixed-line networks reach 14 million homes, serving about 4 million broadband customers. Increasingly, Millicom offers converged packages that include broadband with wireless services. The firm has agreed to acquire Telefonica's operations in Ecuador and Uruguay.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.